March 3, 2026Open Access

IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury

IGFBP4 serves as a biomarker for assessing bile duct injury, potentially aiding diagnosis and treatment.
The data indicates that higher IGFBP4 levels provide protective effects against biliary epithelial cell damage.
Assessment through observational methods emphasizes the association of IGFBP4 with primary biliary cholangitis.
Findings highlight the importance of IGFBP4 in clinical settings, advocating further investigations of its therapeutic potential.

These data highlight that IGFBP4 not only serves as a potential biomarker for PBC but also plays a protective role against bile duct injury.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Liver International

University of California, Davis

University of Milano-Bicocca

Tokushima University

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.